What are the endocrine-targeting drugs?

Generally, endocrine-targeted drugs include tamoxifen citrate tablets, abiraterone acetate tablets, methimazole tablets, octreotide acetate injection, rosiglitazone maleate tablets, etc. The specific analysis is as follows:

1. Tamoxifen Citrate Tablets

Tamoxifen citrate tablets belong to selective estrogen receptor modulators. By binding to estrogen receptors in breast tissue, they block the stimulatory effects of estrogen on breast tissue, thereby inhibiting the growth and metastasis of breast cancer.

2. Abiraterone Acetate Tablets

This is a class of drugs that intervene in disease progression through specific molecular targets. The target of abiraterone acetate tablets is bone-resorbing cells; it can inhibit the activity of these cells, thus reducing the development of osteoporosis.

3. Methimazole Tablets

Methimazole tablets belong to the imidazole class of antifungal agents and are also considered one of the targeted drugs. They interfere with DNA synthesis in yeast and fungi within fungal cells, preventing their growth and reproduction.

4. Octreotide Acetate Injection

Octreotide acetate injection is a medication whose main component is octreotide acetate. Octreotide is a synthetic peptide drug with antitumor activity. By inhibiting the secretion of growth hormone, it suppresses tumor cell proliferation and differentiation, thereby achieving an antitumor effect.

5. Rosiglitazone Maleate Tablets

The main ingredient of rosiglitazone maleate tablets is rosiglitazone, an oral hypoglycemic agent belonging to the biguanide class. It lowers blood glucose levels by reducing hepatic glucose production and enhancing tissue utilization of glucose. It is one of the endocrine-targeted drugs.

If medication is required for treatment, it is recommended to use under the guidance of a qualified physician to avoid improper use that may cause harm to the body.